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Fission yeast Pot1 (protection of telomeres) is a single-stranded telomeric DNA binding protein with a
critical role in ensuring chromosome stability. A putative human homolog (hPot1) was previously identified,
based on moderate sequence similarity with fission yeast Pot1 and telomere end-binding proteins from ciliated
protozoa. Using indirect immunofluorescence, we show here that epitope-tagged hPot1 localizes to telomeres
in interphase nuclei of human cells, consistent with a direct role in telomere end protection. The hPOT1 gene
contains 22 exons, most of which are present in all cDNAs examined. However, four exons are subject to exon
skipping in some transcripts, giving rise to five splice variants. Four of these are ubiquitously expressed,
whereas the fifth appears to be specific to leukocytes. The resultant proteins vary significantly in their ability
to form complexes with single-stranded telomeric DNA as judged by electrophoretic mobility shift assays. In
addition to these splice variants, the Pot1 family is expanded by the identification of six more genes from
diverse species. Pot1-like proteins have now been found in plants, animals, yeasts, and microsporidia.
Telomeres, the protein-DNA complexes at eukaryotic chro-
mosome ends, protect the termini from end-to-end fusions and
nucleolytic degradation. In most cells the DNA portion of
telomeres consists of short repeats, which are rich in guanines
on the strand running 5 to 3 towards the chromosome end.
This strand is synthesized by the ribonucleoprotein complex
telomerase. The catalytic subunit, telomerase reverse tran-
scriptase (TERT), uses part of an RNA subunit as a template
for DNA synthesis (14, 21). Telomeres range in length from 50
bp in hypotrichous ciliated protozoa to 150 kb in some strains
of mice, with the length of each telomere usually fluctuating
around a species-specific mean value. In all organisms where
telomeres have been examined more closely, a 3 overhang of
the G-rich strand is present at the termini (1, 18, 22, 23, 37, 39).
Numerous proteins have been identified that bind to the
double- or single-stranded portion of telomeres and play roles
in end protection and telomere length regulation (reviewed in
reference 3). In Oxytricha nova, a hypotrichous ciliate, a telo-
mere end-binding protein (TEBP), consisting of  and  sub-
units, binds specifically to the single-stranded DNA overhangs
at the ends of telomeres (8, 12, 13). The crystal structure of this
ternary complex revealed the presence of four oligonucleotide/
oligosaccharide binding folds (OB-folds), three of which are
involved in DNA binding and one of which is involved in
protein-protein interactions (16). Related proteins have been
found in other ciliated protozoa including Stylonychia mytilis
(10) and Euplotes crassus (36); the latter contains two proteins
related to the  subunit but apparently contains no  subunit.
In Saccharomyces cerevisiae, the single-stranded overhang is
bound by Cdc13, a protein with a pivotal role in protecting the
chromosome end (11, 30) and in recruiting telomerase to the
telomere (7) or activating it at the telomere (34). Single-
stranded telomeric DNA binding proteins are not the only
solution to end protection, however. Telomeres from humans,
trypanosomes, and ciliate germ line nuclei have all been re-
ported to form T-loop structures in which the single-stranded
overhang is inserted into the upstream double-stranded region
(15, 26, 27). In vitro, T-loop formation is facilitated by the
telomere repeat binding factor Trf2 (15). Consistent with a
role of Trf2 in end protection, a dominant-negative version of
the protein causes a loss of G-strand overhangs and end-to-end
fusions (35).
Recently a single-stranded telomeric DNA binding protein
has been identified in Schizosaccharomyces pombe (1). The
protein shares weak sequence similarity with the N-terminal
DNA binding domain of TEBPs from ciliated protozoa and
was named Pot1 (protection of telomeres) based on the rapid
loss of telomeric DNA that occurs following deletion of the
gene. Whereas most cells lacking Pot1 die due to sequence loss
and end-to-end chromosome fusions, a few survivors emerge
that have circularized all three chromosomes, thereby escaping
the need for chromosome end maintenance. A human se-
quence homolog of the S. pombe protein has also been de-
scribed (1). Purified fission yeast and human Pot1 (hPot1)
proteins bind specifically to the G-rich strand of their own
telomeric DNA but not to the complementary C-rich strand or
double-stranded telomeric DNA, consistent with a role in
binding to the 3 overhang at the ends of telomeres in vivo (1).
Here we show by indirect immunofluorescence that the
hPot1 protein resides at the telomeres in vivo as judged by
colocalization with the telomere repeat binding factor Trf2 and
hRap1. Together with previous results, this finding strongly
suggests that hPot1 is a bona fide telomere end-binding protein
and a functional homolog of S. pombe Pot1 (SpPot1). Based on
sequence similarity, six new members of the Pot1/TEBP family
are identified from diverse organisms including mouse and
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mustard weed. We have further analyzed the human and
mouse POT1 gene structure and isolated five splice variants of
hPOT1, for which tissue-specific expression and distinct DNA-
binding properties are presented.
MATERIALS AND METHODS
Cloning and plasmids. The plasmid pPB330 was constructed by inserting
full-length hPOT1 cDNA into the plasmid pcDNA/FRT/V5-His (Invitrogen)
such that the protein is expressed in-frame with C-terminal V5 and His6 tags.
Plasmid pPB341 is a derivative of pIND V5-His C (Invitrogen) containing full-
length hPOT1 cDNA under the control of a ponasterone A-inducible promoter.
Human POT1 splice variants were amplified by PCR from human cDNA using
primers TCTACAGAATCAATGTCTTTGGTTCCAGC and GATTACATCT
TCTGCAACTGTGGTGTCA. PCR products were gel purified, cloned into the
plasmid pCR2.1 TOPO (Invitrogen), and analyzed by automated sequencing.
Cell culture, transfection, and immunofluorescence. EcR293 cells were main-
tained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum, L-glutamine (2 mM), and Zeocin (0.4 mg/ml). HeLaI.2.11 cells
were maintained in Dulbecco’s modified Eagle’s medium supplemented with
10% fetal bovine serum, L-glutamine (2 mM), and 1 nonessential amino acids
(Invitrogen).
For analysis by immunofluorescence, cells were seeded onto coverslips in
tissue culture dishes. After 16 h, cells were transfected with the plasmid pPB341
(EcR293) or the plasmid pPB330 (HeLaI.2.11) using lipofectamin 2000 (Invitro-
gen). The medium was replaced after 4 h, and after 24 h expression of V5-tagged
hPot1 was induced in EcR293 cells by addition of ponasterone A to a final
concentration of 3 M.
Forty-eight hours posttransfection, cells were washed twice in phosphate-
buffered saline (PBS) and fixed for 10 min in 4% formaldehyde. Cell membranes
were permeabilized with 0.1% Triton X-100 in PBS for 10 min. After a brief rinse
in PBS, cells were incubated for 1 h in 1% bovine serum albumin in PBS followed
by 1 h in a solution containing PBS, 1% bovine serum albumin, and primary
antibodies. V5-tagged hPot1 was detected using a monoclonal mouse anti-V5
antibody (Invitrogen) at a concentration of 1 g/ml. Polyclonal antibodies
against hRap1 (#666) were a generous gift from Titia de Lange and were used
at a 1:1,000 dilution. Polyclonal antibodies against Trf2 were purchased from
Santa Cruz Biotechnology and used at a concentration of 0.2 g/ml. After four
10-min washes in PBS, samples were incubated for 1 h with secondary antibodies
Alexa Fluor 488 goat antimouse and Alexa Fluor 594 goat antirabbit (Molecular
Probes) at a concentration of 2 g/ml. Prior to being mounted on slides, the
coverslips were washed three times in PBS containing 1% bovine serum albumin
and twice in PBS. DNA was visualized by adding 4,6-diamidino-2-phenylindole
(0.2 ng/ml) to the final wash. Images were acquired using a Zeiss Axioplan 2
microscope equipped with a charge-coupled device camera. Images were merged
and analyzed using Slidebook software (Intelligent Imaging).
Expression analysis. Expression levels of hPOT1 in different tissues were
assessed using first-strand cDNA panels (Clontech) normalized to the expression
of four housekeeping genes. Transcripts were amplified using AdvanTaq Plus
polymerase (Clontech) and the following pairs of oligonucleotides: GGGCAA
AGCAGAAGTGGACGGAGCATC and ATTGACAGATAACATCTGAATG
CTGATTGGCTGTC (exons 9 to 12); TTCAGATGTTATCTGTCAATCAGA
ACCTG and ATGTATTGTTCCTTGTATAAGAAATGGTGC (exons 12 to
16); CAGCACCATTTCTTATACAAGGAACAATAC and GATTACATCTT
CTGCAACTGTGGTGTCA (exons 16 to 20); ACACCCCTGAATCAACTTA
AGGGTGGT and ATTGACAGATAACATCTGAATGCTGATTGGCTGTC
(exons 6 to 12). Template DNA was denatured at 94°C for 30 s, and hPOT1
fragments were amplified using the following cycling parameters: 94°C for 5 s,
72°C for 120 s (5 cycles); 94°C for 5 s, 70°C for 120 s (5 cycles); and 94°C for 5 s,
68°C for 120 s (26 cycles). Samples were taken after a total of 28, 30, 32, and 34
cycles. As a control, G3PDH was amplified under the same conditions for 22, 24,
and 26 cycles with the primers TGAAGGTCGGAGTCAACGGATTTGGT and
CATGTGGGCCATGAGGTCCACCAC. Reaction products were subjected to
electrophoresis on 1.1% Tris-borate EDTA agarose gels run for 2.5 h followed
by staining with Vistra Green (1 g/ml; Molecular Probes) for 1 h. The relative
abundance of PCR products was determined using a Typhoon PhosphorImager
and ImageQuant software. For each PCR product the rate of accumulation was
monitored to ensure that comparisons were made within the linear range for all
samples. Each experiment also included a no-cDNA control to ensure the ab-
sence of contamination.
In vitro translation and DNA binding. Human POT1 splice variants 1, 2, 3, and
5 were subcloned into a T7 expression vector for in vitro protein expression using
the TNT coupled reticulocyte lysate kit (Promega). In a 50-l reaction mixture,
3 g of plasmid DNA was incubated with 4 l of [35S]methionine (1,000 Ci/
mmol; 10 mCi/ml) and 25 l of rabbit reticulocyte lysate under the conditions
recommended by the manufacturer. A fraction of each reaction was analyzed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and relative amounts
of produced protein were quantified using a PhosphorImager.
DNA binding assays (10-l reaction mixtures) contained 2 l of translation
reaction product, the 5 32P-labeled telomeric oligonucleotide GGTTAGGGTT
AGGGTTAGGG, 25 mM HEPES–NaOH (pH 7.5), 100 mM NaCl, 1 mM
EDTA, and 5% glycerol. Herring sperm DNA (50 g/ml) and the oligonucleo-
tide TTAATTAACCCGGGGATCCGGCTTGATCAACGAATGATCC (2.5
M) were added as nonspecific competitors. Where appropriate, RNA oligonu-
cleotide (UUAGGG)5 was added to a 2.5 M final concentration. Reactions
were incubated for 10 min at room temperature, and protein-DNA complexes
were analyzed by electrophoresis at 4°C on a 4 to 20% polyacrylamide Tris-
borate EDTA gel run at 150 V for 80 min.
RESULTS
Immunolocalization of hPot1. Previous work has shown that
purified hPot1 protein binds specifically to the G-rich strand of
telomeric DNA (1), suggesting that in vivo the protein may
bind to the single-stranded extension of the G-rich strand at
the ends of chromosomes. To examine the subcellular local-
ization of hPot1, human embryonic kidney EcR293 cells were
transiently transfected with a plasmid encoding V5-epitope-
tagged hPot1. Detection of hPot1 by indirect immunofluores-
cence revealed a punctate nuclear staining pattern in inter-
phase nuclei (Fig. 1A and D). No staining was observed in cells
transfected with an empty control vector or a plasmid encoding
hPot1 lacking the V5-epitope tag (data not shown).
The hRap1 protein has been shown to localize to telomeres
via its interaction with Trf2 (20). To determine whether the
nuclear hPot1 foci coincide with hRap1 staining and hence the
telomeres, hRap1 was visualized using a polyclonal antibody
raised against the protein (Fig. 1B and E). An overlay of the
two images revealed a strong correlation in the staining pat-
terns, indicated by the yellow color (Fig. 1C and F). Nuclei
which did not express V5-tagged hPot1, presumably because
they were not transfected, showed only the hRap1 staining and
no yellow foci (top nucleus in Fig. 1A to C and bottom nucleus
in Fig. 1D to F).
HeLaI.2.11 cells are a subclone of HeLaI (31) containing
exceptionally long telomeres of 25 to 40 kb (35). Due to the
increased number of binding sites per telomere, these cells
have proven particularly useful in the immunolocalization of
telomeric proteins (32, 33, 35). After transfection of these
HeLa cells with a plasmid encoding V5-epitope-tagged hPot1,
distinct nuclear foci were observed in interphase nuclei by
indirect immunofluorescence (Fig. 2A and D). Staining of the
same cells for hRap1 (Fig. 2B) or Trf2 (Fig. 2E) also resulted
in a punctate nuclear pattern as previously reported (2, 4, 20).
In each case the majority of hPot1 foci coincided with hRap1
(Fig. 2C) or Trf2 (Fig. 2F). We therefore conclude that hPot1
is present at the telomeres in interphase nuclei of EcR293 and
HeLaI.2.11 cells.
Evolutionary conservation of Pot1 proteins. The fission
yeast and human Pot1 proteins were identified owing to a weak
sequence similarity with the N-terminal regions of telomere
end-binding proteins from ciliated protozoa (1). Based on the
assumption that this family of proteins might be more widely
conserved, we used PSI-BLAST to search for members in
other organisms. A cDNA from the green monkey Macaca
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fascicularis was found to be 98% identical (99% similar) to
human Pot1 over the entire length of the open reading frames.
A mouse homolog was identified based on a sequence identity
of 75% (84% similarity).
Unlike the case for the human, monkey, and mouse se-
quences, the similarity of human and fission yeast Pot1 with the
ciliate telomere end-binding proteins is limited to approxi-
mately the N-terminal fifth of the proteins (1). Using this
N-terminal region of hPot1 in a PSI-BLAST search, we iden-
tified several other putative family members (E value of
1028). Notably, there appear to be two proteins in Arabi-
dopsis thaliana that fall into this category (sequence accession
number NP_196249, E 	 8  1054 after two rounds; and
sequence accession number NP_178592, E 	 1028 after three
rounds). Because the NP_196249 protein is more closely re-
lated to the Pot1 proteins from other organisms, this protein
was named AtPot1, whereas the NP_178592 protein is referred
to as AtPot2. Other candidate family members were identified
in the yeast Neurospora crassa (accession number CAD11392;
E 	 4  1033 after four rounds) and in the microsporidium
Encephalitozoon cuniculi (accession number CAD26625) (E 	
1034 after four rounds). An alignment of the N-terminal re-
gions of Pot1 proteins revealed the presence of a few key
residues that are conserved between all sequences (Fig. 3).
Genomic sequence and gene structure. Using sequence data
from BAC clones RP11-304A23 (accession number
AC096665), RP11-563L14 (AC110791), and RP5-907C10
(AC004925), we assembled a genomic sequence of approxi-
mately 120 kb spanning the entire hPOT1 gene. The gene is
located on chromosome 7. The positions of 22 exons were
mapped based on cDNA sequences and consensus splice sites
(Fig. 4A). The assembled DNA sequence can be viewed at
http://petunia.colorado.edu/pot1/hpot1_gdna.html.
The genomic sequence of mouse POT1 (MmPOT1) was ex-
tracted from the Celera database using the MmPot1 protein
sequence and BLAST. Based on cDNAs BC016121 and
NM_133931 as well as our own sequencing data, we mapped 18
exons onto the genomic DNA (Fig. 4A). The exon containing
the start codon was given the number 6 to facilitate comparison
with the human sequence. The exon size and the position of
splice sites are highly conserved between human and mouse for
exons 6 to 20. The mouse POT1 gene spans approximately 70
kb on chromosome 6.
In eukaryotes, protein synthesis usually begins with the first
FIG. 1. Human Pot1 protein colocalizes with hRap1 in EcR293 cells. Actively growing cells expressing V5-epitope-tagged hPot1 were fixed in
formaldehyde and stained for Pot1 with a monoclonal V5 antibody and for hRap1 with a polyclonal rabbit antibody. Nuclei were visualized by
4,6-diamidino-2-phenylindole staining of chromosomal DNA. (A and D) Nuclear hPot1 foci (green). Due to the nature of transient transfections,
not all cells express V5-tagged Pot1. (B and E) hRap1 staining (red). (C) Merged images from panels A and B; colocalization of V5-hPot1 and
hRap1 is indicated by yellow color. (F) Merged images from panels D and E.
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AUG codon from the 5 end of an mRNA. Surprisingly, the
AUG we had previously predicted as the start of the 634-
amino-acid hPot1 protein maps to the 6th exon in the human
sequence and is the 10th AUG from the 5 end of the most
complete cDNA available to us (hCT24115; Celera). If trans-
lation was initiated at any of the first nine AUGs (Fig. 4B), the
resulting peptides would be between 4 and 71 amino acids in
length, because each AUG is followed by an in-frame stop
codon. Barring complex translational frame-shifting, the bulk
of the hPot1 protein would be produced only if the 10th AUG
were used. Neither the 10th nor any of the preceding AUGs is
embedded within a Kozak consensus sequence for initiation of
translation (19).
The existence of several exons and AUGs upstream of the
POT1 start codon is conserved in mouse and Macaca (data not
shown). In the MfPOT1 cDNA (sequence accession number
AB066545), all exon sizes are conserved with those of human
sequence, and the DNA sequences corresponding to exons 2 to
6 are 97% identical with the human sequence (data not
shown). For the most complete cDNA isolated from mouse,
the 5 untranslated region consists of three exons.
Expression of hPOT1 splice variants. Human POT1 was first
cloned from ovary cDNA by amplifying the predicted open
reading frame using primers corresponding to sequences in
exons 6 and 20. Sequencing of the cloned PCR products re-
vealed the presence of four alternatively spliced forms of
hPOT1 (Fig. 4B). Splice variant 1 is the form previously de-
scribed by members of our group (1) and is identical to several
cDNA sequences deposited in the public database (e.g.,
NM_015450, AK001935, AK001230, AK022580, and
BC002923). In variant 2, use of an alternative 5 splice site adds
exon 12a between exons 12 and 13. Although the isolated
cDNAs included exons 13 to 20, a stop codon in exon 12a is
expected to terminate translation, resulting in a 38-kDa pro-
tein. Variants 3 and 4 originate by exon skipping of exon 17
and exon 8, respectively. The protein produced from a message
lacking exon 17 should be 58 kDa in size, since splicing of exon
16 to exon 18 results in a change of open reading frame and
termination within exon 18. Similarly, skipping of exon 8
should result in a truncated protein of only 5 kDa.
A fifth splice form was identified when hPOT1 was amplified
and cloned from cDNA isolated from peripheral blood leuko-
FIG. 2. Colocalization of hPot1 with hRap1 and Trf2 in HeLaI.2.11 cells. Actively growing cells expressing V5-epitope-tagged hPot1 were fixed
in formaldehyde and stained for Pot1 with a monoclonal V5 antibody and for hRap1 or Trf2 with polyclonal rabbit antibodies. Nuclei were
visualized by DAPI staining of chromosomal DNA. (A and D) Nuclear hPot1 foci (green). (B) hRap1 staining (red). (C) Merged images form
panels A and B; colocalization of V5-hPot1 and hRap1 is indicated by yellow color. (E) hTrf2 staining (red). (F) Merged images from panels D
and E.
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cytes. This form includes an additional exon 15a between exons
15 and 16 (Fig. 4B). Exon 15a harbors a stop codon in-frame
with the hPOT1 open reading frame, resulting in the produc-
tion of a 52-kDa protein.
Multitissue cDNA panels were used to systematically survey
for the presence of splice variants in different tissues by PCR.
This method allows unambiguous identification of different
splice forms and is more sensitive than Northern analysis. A
number of primer pairs were synthesized, each covering a
region of the sequence. Because no variation had been ob-
served between exons 9 and 12, primers spanning this region
were used to compare the total levels of all hPOT1 transcripts
between different tissues. Differences in the amount of cDNA
used from each tissue were accounted for by normalizing the
hPOT1 PCR amplification products against a 
1-kb fragment
of the housekeeping gene for glyceraldehyde-3-phosphate de-
hydrogenase (G3PDH), which was amplified in parallel. To
compare the relative amounts of hPOT1 mRNA within each
panel, the values obtained for the heart and spleen were set to
1. Although hPOT1 expression was observed in all tissues, it
was highest in testis and low in skeletal muscle and colon (Fig.
5A). Human Pot1 expression was also detected in eight sam-
ples of cDNA derived from a variety of carcinomas and ade-
nocarcinomas (Fig. 5B). The ubiquitous presence of hPOT1
mRNA suggests that the protein plays a role in the mainte-
nance of telomeres in all cells, unlike TERT, which is predom-
inantly found in the germ line and in tumors.
The presence or absence of splice variant 2 in different
tissues was assayed using a primer pair spanning exons 12 to
16. PCR from all tissues produced two bands, and sequencing
confirmed that inclusion of exon 12a was responsible for the
production of the upper band (Fig. 5C and data not shown).
Due to the low transcript levels in colon and skeletal muscle,
the presence of splice variant 2 was confirmed after additional
rounds of amplification (data not shown). When cDNA de-
rived from peripheral blood leukocytes was used in the PCR
spanning exons 12 to 16, a new PCR product was detected.
Sequencing revealed that this additional product included exon
15a (splice variant 5; Fig. 4B).
Primer pairs spanning exons 16 to 20 and exons 6 to 12 were
used to detect splice variants 3 and 4, respectively. Skipping of
exon 17 (variant 3) and exon 8 (variant 4) was apparent in all
tissues (Fig. 5C). We conclude that splice variants 1 to 4 coexist
in all tissues examined, whereas splice variant 5 was detected
only in peripheral blood leukocytes.
DNA binding activity of proteins encoded by splice variants.
Sequence alignments and structural comparison of hPot1 with
ciliate telomere end-binding proteins suggested that the N-
terminal region of hPot1 is responsible for DNA binding (1,
29). As this region is present in splice forms 1, 2, 3, and 5, we
wanted to test whether the encoded proteins would interact
with telomeric DNA. The four variants were expressed in rab-
bit reticulocyte lysate in the presence of [35S]methionine and
gave rise to proteins of the expected relative sizes (Fig. 6A).
When incubated with telomeric DNA, a distinct shift was
observed for each splice variant (Fig. 6B). Intriguingly, the
amount of protein-DNA complex formed with variant 2 was
sixfold greater than for variant 1, suggesting a higher affinity of
the former splice form for telomeric DNA (lanes c and d).
Moreover, variants 3 and 5 produced only weak bands corre-
sponding to hPot1-DNA complexes (lanes e and f). When
different concentrations of the proteins were incubated to-
gether, competing for binding to the telomeric DNA, the ap-
parent binding affinity of variant 2 was 8 to 9 times greater than
FIG. 3. Alignment of N-terminal regions of Pot1-like proteins from Homo sapiens (Hs) (sequence accession number AK001935), M. fascicularis
(Mf) (BAB62219), Mus musculus (Mm) (AAH16121), A. thaliana (At1, NP_196249; At2, NP_178592), E. cuniculi (Ec) (CAD26625), S. pombe (Sp)
(NP_594453), and N. crassa (Nc) (CAD11392). Protein sequences were aligned in ClustalW using the default values. Amino acids identical or
similar in more than four sequences are shown as black letters shaded in gray, amino acids identical or similar in more than six sequences are shown
as white letters shaded in gray, and those identical or similar in all sequences are shaded black. The first and last amino acid positions are indicated
for each sequence.
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that of variant 1, 
20 times greater than that of variant 3, and

30 times greater than that of variant 5 (data not shown).
Variant 5 formed a complex of much greater electrophoretic
mobility than expected from its protein molecular weight rel-
ative to the other variants. This could represent a different
stoichiometry of binding or a more compact conformation of
the protein-DNA complex.
Addition of an excess of unlabeled RNA oligonucleotide of
telomeric sequence eliminated most of the background binding
of proteins from the reticulocyte lysate to the telomeric DNA
oligonucleotide (compare lanes b in Fig. 6B and C). The rel-
ative differences in amounts of DNA-Pot1 variant complexes
and their electrophoretic mobilities persisted in the presence
of the RNA competitor (Fig. 6C) as well as at two different
protein concentrations (data not shown). In summary, the four
splice variants of hPot1 appear to have quite different telo-
meric DNA binding properties and may therefore play distinct
roles in telomere maintenance.
DISCUSSION
Using indirect immunofluorescence, we show here that
epitope-tagged hPot1 localizes to distinct nuclear foci in
EcR293 and HeLa cells. The hPot1 staining largely coincides
with the position of telomeres as evidenced by dual labeling for
other telomeric proteins, namely hRap1 and Trf2. Together
with the sequence similarity between human and S. pombe
Pot1 proteins and biochemical analysis of single-stranded te-
lomeric DNA binding (1), these results strongly suggest that
hPot1 is indeed a telomeric protein.
Database searches revealed new homologs of the human and
fission yeast Pot1 proteins in diverse species including animals,
plants, fungi, and microsporidia. This wide distribution of
Pot1/TEBP family members leads us to speculate that related
telomere end-binding proteins are likely to be present in most
eukaryotes. We have sequenced four new splice variants of
human POT1 and mapped the exons of the human and mouse
proteins onto the respective genomic sequences. Amplification
of mRNA demonstrated that four splice variants are expressed
in a wide variety of tissues, whereas the fifth splice variant
appears to be specific to peripheral blood leukocytes. Notably,
four of the five Pot1 protein variants have distinct DNA-bind-
ing properties, indicating that they may fulfill different func-
tions within the cell.
A growing family of single-stranded telomeric DNA binding
FIG. 4. Gene structure and splice variants of hPOT1. (A) Structural organization of human and mouse POT1 genes. Exons are indicated by
vertical bars and were numbered after the 20 exons found in the hPOT1 cDNA clone hCT24115 were mapped onto the genomic sequence. The
5 ends of other hPOT1 cDNA clones are located in exons 2 (accession number AK022580) and 5 (AK001935 and BC002923). Exons specific to
splice variants 2 and 5 are numbered 12a and 15a, respectively. Translation of human and mouse POT1 starts in exon 6 and ends in exon 20.
(B) Structure of the hPOT1 splice variants. Exons are shown as white boxes (length proportional to exon size); introns are generally long and are
not shown to scale. Skipping of an exon is indicated by a bracket below the box. The protein products are shown under each splice variant as black
bars. For splice variant 1 the positions of the first 10 AUGs are indicated by asterisks.
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proteins. Until recently, telomere end-binding proteins, as first
described for O. nova (12, 13), were thought to be specific to
ciliated protozoa. This perception was largely based on the
inability to identify related genes from other species based on
sequence homology and the fact that the structure of a T-loop
seemed incompatible with the presence of a DNA end-binding
protein. The exponential increase in available sequence data
finally led to the identification of the fission yeast and human
Pot1 proteins (1), followed by putative homologs in macaque
monkeys, mice, mustard weed, N. crassa, and E. cuniculi.
The difficulty in identifying members of this family is due to
the small amount of primary sequence conservation that is
FIG. 5. Expression analysis of hPOT1 splice variants. (A) Exons 9 to 12 of hPOT1 were amplified from multitissue cDNA panels, and relative
expression levels compared to those for heart (top panel) and spleen (bottom panel) are given. G3PDH was amplified in parallel and used for
normalization. (B) Same as panel A except that cDNA samples isolated from tumors were used: breast carcinoma gi-101, lung carcinoma gi-117,
colon adenocarcinoma cx-1, lung carcinoma lx-1, prostatic adenocarcinoma pc-3, colon adenocarcinoma gi-112, ovarian carcinoma gi-102, and
pancreatic adenocarcinoma gi-103. Breast carcinoma gi-101 was used for normalization. (C) The following regions of hPOT1 mRNA were
amplified to detect the presence of different splice forms: exons 12 to 16; products containing exon 12a (variant 2) or exon 15a (variant 5) are
indicated by arrows. Exons 16 to 20; product lacking exon 17 (variant 3) is indicated. Exons 6 to 12; product lacking exon 8 (variant 4) is indicated.
The unmarked band in each lane corresponds to transcripts that are not variant in this region.
FIG. 6. Binding of hPot1 splice variant proteins to telomeric DNA. (A) sodium dodecyl sulfate-polyacrylamide gel showing in vitro-translated
35S-labeled splice forms 1, 2, 3, and 5. These variants contain 12, 6, 6, and 6 methionine residues, respectively, which accounts for their different
signal strengths. Quantification revealed that actual expression levels are within 1.5-fold of each other. (B) Electrophoretic mobility shift assay of
a 32P-labeled telomeric oligonucleotide in the presence of hPot1 variants. Protein-DNA complexes specific to hPot1 variants are indicated by
asterisks. The three bands seen above the free DNA in lane b represent proteins from the reticulocyte extract binding to the telomeric DNA
oligonucleotide and persist in lanes c to f. (C) As with panel B, except that RNA oligonucleotide (UUAGGG)5 was added as competitor.
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necessary to maintain the structure of an OB-fold (28). This
point was nicely illustrated by a recent report on the nuclear
magnetic resonance structure of the budding yeast Cdc13 pro-
tein (24). Although no sequence similarity was apparent be-
tween Cdc13 and TEBPs or Pot1, the Cdc13 DNA-binding
domain conforms to the OB-fold and is structurally similar to
the N-terminal OB-fold of O. nova TEBP. This exciting finding
suggests that the OB-fold may be a universally conserved struc-
ture for binding of single-stranded telomeric DNA. There are
also some functional similarities between SpPot1 and Cdc13,
since deletion of either protein leads to a rapid loss of telo-
meric DNA (1, 11). It is currently unclear, however, whether
there is an ancestral relationship between Cdc13 and Pot1/
TEBP or whether convergent evolution may explain the struc-
tural similarity. An important question to answer in this con-
text is whether Pot1 proteins play the same pivotal role as
Cdc13 in recruiting telomerase as well as an Stn1-containing
protective complex (30).
Splice variants with distinct biochemical properties. The
observation that the hPOT1 gene may encode at least five
distinct proteins adds to the growing list of examples demon-
strating that much of the complexity of higher organisms arises
from alternative splicing (25). Alternative splicing has also
been reported for the human TERT gene (17, 38), and telom-
erase activity appears to be regulated, at least in part, via
alternative splicing, resulting in the production of inactive or
dominant-negative forms of hTERT (5, 6, 40).
It is tempting to speculate that the hPot1 variants will have
distinct functions in vivo, since they interact differently with
telomeric DNA. Most interestingly, splice variant 2 protein,
which lacks almost half the sequence of variant 1, appeared to
have the highest affinity for DNA. Increased DNA binding
affinity following truncation of the C terminus has previously
been reported for SpPot1 (1) and O. nova TEBP (9). The
human protein, however, provides the first example where the
shorter version could be produced in vivo via alternative splic-
ing. It will be of interest to determine whether different splice
forms associate with the telomere during specific stages of the
cell cycle, or whether they may interact with the telomere in
different conformations—such as within the structure of a T-
loop or with the open conformation. In addition to modulating
the affinity for telomeric DNA, the different C termini may also
be involved in mediating contacts with additional proteins.
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